ARCHIVES

CTAC Discussion, Group Chairs Comment

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

In Brief: Baltimore Names ACS Research Professor; Currie, Sachdeva Lead Education Association

December 9, 1994

The 99th turned Out Well For Cancer Program, But Several Important Issues Await 100th Congress

October 31, 1986

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994